ArticleMolecular cancer therapeutics2020

Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability.

Dina V Hingorani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.